Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Daiichi Sankyo
Pharma
Takeda, Daiichi, Astellas and more—Fierce Pharma Asia
Takeda's first-in-class narcolepsy drug won an FDA nod. Daiichi admitted to an accounting error. Astellas hit record revenue.
Angus Liu
Aug 7, 2026 8:35am
Daiichi Sankyo flags accounting error; shares tank
Jul 31, 2026 11:39am
Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia
Jun 26, 2026 8:51am
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC
Jun 24, 2026 5:00pm
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
AZ, Daiichi's Datroway approved in first-line TNBC
May 22, 2026 11:32am
